{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:27Z","timestamp":1755216747564,"version":"3.43.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Hepatic veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) is one of the most severe and life-threatening complications after hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is approved for adult and pediatric patients with VOD\/SOS with renal or pulmonary dysfunction after HSCT in the United States, and for severe VOD\/SOS post-HSCT in patients above 1 month of age in the European Union. Several studies have examined whether DF prophylaxis can reduce the incidence of VOD\/SOS in high-risk patients. A total of 334 pediatric allogeneic HSCT were included in this study. All patients received DF at the dose of 25\u2009mg\/kg\/d, from the first day of the conditioning regimen to the 30th day after transplantation for VOD\/SOS prophylaxis. Seventeen patients (5.08%) developed VOD\/SOS; 4 of these had moderate, while 13 had mild VOD\/SOS. None of the patients were developed severe or very severe VOD\/SOS. In conclusion, we showed that prophylactic intervention with DF lowered the incidence of VOD\/SOS in high-risk pediatric patients.<\/jats:p>","DOI":"10.1097\/mph.0000000000002379","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T10:18:15Z","timestamp":1640859495000},"page":"e35-e39","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Prophylaxis of Hepatic Veno-Occlusive Disease\/Sinusoidal Obstruction Syndrome With Defibrotide After Hematopoietic Stem Cell Transplantation in Children: Single Center Experience"],"prefix":"10.1097","volume":"44","author":[{"given":"Barbaros S.","family":"Karagun","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Bone Marrow Transplantation Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuana","family":"Akbas","sequence":"additional","affiliation":[{"name":"Department of Radiology, Acibadem University Faculty of Medicine, Adana Hospital, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Erbey","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, Ko\u00e7 University School of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lgen","family":"Sasmaz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Bone Marrow Transplantation Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Antmen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Bone Marrow Transplantation Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-20250804","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17474124.2017.1370372","article-title":"Defibrotide for children and adults with hepatic venoocclusive disease post hematopoietic cell transplantation","volume":"11","author":"Corbacioglu","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","article-title":"Defibrotide for the prevention of hepatic venoocclusive disease after hematopoietic stem cell transplantation: a systematic review","volume":"26","author":"Zhang","year":"2012","journal-title":"Clin Transplant"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"Mcdonald","year":"1984","journal-title":"Hepatology"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MPH.0000000000000799","article-title":"The diagnostic value of hepatic arterial velocity in venoocclusive disease after pediatric hematopoietic stem cell transplantation","volume":"39","author":"Kaya","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"R11-20250804","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic venoocclusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2141.2009.07871.x","article-title":"Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan","volume":"147","author":"Cappelli","year":"2009","journal-title":"Br J Haematol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.bbmt.2019.12.655","article-title":"A systematic review of studies of defibrotide prophylaxis for veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"26","author":"Corbacioglu","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbmt.2017.03.022","article-title":"Cost effectiveness of defibrotide in the prophylaxis of veno-occlusive disease after pediatric allogeneic stem cell transplantation","volume":"23","author":"Pichler","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"e27269","DOI":"10.1002\/pbc.27269","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome following nontransplantassociated chemotherapy: final results from a post hoc analysis of data from an expanded-access program","volume":"65","author":"Kernan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ehm.12.18","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"5","author":"Corbacioglu","year":"2012","journal-title":"Expert Rev Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:14:27Z","timestamp":1754338467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002379","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"assertion":[{"value":"2020-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}